+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
ADMA Biologics Inc - logo

ADMA Biologics is a late stage biopharmaceutical company that develops specialty plasma-based biologics for the treatment and prevention of immune deficiencies and infectious diseases. Its lead product candidate is RI-002 derived from human plasma, which has completed Phase III clinical study for the treatment of primary immune deficiency disease. ADMA Biologics was founded in 2004 and is based in Ramsey, New Jersey.

Lupus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Lupus Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 182 Pages
  • Global
From
From
Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2024 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 180 Pages
  • Global
From
From
From
From
From
From
From
Immunoglobulins: Global Market Outlook - Product Thumbnail Image

Immunoglobulins: Global Market Outlook

  • Report
  • March 2023
  • 64 Pages
  • Global
From
From
Primary Immunodeficiency Therapeutics Market 2024-2028 - Product Thumbnail Image

Primary Immunodeficiency Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 136 Pages
  • Global
From
Loading Indicator